Olmesartan HCT Tablet 5/20/12.5 mg

Adult dose

This medication should be taken once daily, with one tablet taken with water, regardless of meals. It is recommended to take it at the same time daily (e.g., in the morning). Dosage is as follows: - 5/20/12.5 mg: For patients whose blood pressure is not adequately controlled with a combination therapy of amlodipine/olmesartan medoxomil 5/20 mg. - 5/40/12.5 mg: For patients whose blood pressure is not adequately controlled with a combination therapy of amlodipine/olmesartan medoxomil 5/40 mg.

Child dose

The safety and efficacy of this medication in pediatric patients under 18 years of age have not been established, so its administration is not recommended.

This drug may cause serious harm or even death to the fetus and newborn during the second and third trimesters of pregnancy, so if pregnancy is confirmed, it should be discontinued immediately. Patients with hypersensitivity to this medication or its components, certain heart diseases, kidney disorders, or liver disorders should not take this medication. Special caution is needed for patients with decreased blood volume or impaired kidney function, as hypotension or worsening kidney function may occur. Patients with liver disease or severe heart valve disease also require special caution when using this drug. Since this medication lowers blood pressure, care should be taken to avoid excessive hypotension when taken with other antihypertensive medications. In particular, patients with diabetes or moderate to severe kidney impairment should not take this drug with certain medications and should consult with their doctor in such cases. During the course of this medication, blood electrolyte levels and kidney function should be regularly monitored to ensure that no abnormalities occur. As phototoxic reactions may occur, caution should be taken to avoid excessive sun exposure, and if skin rashes or itching occur, consultation with a physician should be sought immediately. Common side effects may include dizziness and headaches, so care should be taken when driving or operating dangerous machinery. If severe allergic reactions, respiratory difficulties, or swelling occur, use should be discontinued immediately, and medical assistance should be sought. In case of overdose, severe hypotension or arrhythmias may occur, so emergency treatment should be sought if symptoms appear. The safety and efficacy of this drug in children have not been established, so its administration is not recommended; elderly patients may require dosage adjustments due to decreased kidney and liver function. Women who are breastfeeding should not use this drug, as it may be secreted in breast milk and could affect the baby.

Serious side effects

Urticaria, angioedema, Quincke's edema, Stevens-Johnson syndrome, vasculitis (including necrotizing vasculitis), acute renal failure, acute interstitial pneumonia, acute respiratory distress syndrome, pulmonary edema, respiratory distress, respiratory distress syndrome, jaundice (cholestatic jaundice), altered consciousness (loss of consciousness, etc.), seizures, paralysis, myocardial infarction, thrombosis, embolism, acute cholecystitis, acute renal failure, acute angle-closure glaucoma, acute respiratory distress syndrome

Mild side effects

• Peripheral edema
• headache
• dizziness
• upper respiratory infection
• nasopharyngitis
• urinary tract infection
• sialoadenitis
• leukopenia
• thrombocytopenia
• bone marrow suppression

This medication should be stored in a tightly closed container to prevent exposure to air or moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius. This will help ensure the effectiveness and safety of the drug for an extended period.

Appearance

White-orange round film-coated tablets

Package unit

30 tablets/box (10 tablets/Alu-Alu×3)